|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0006142,
umls-concept:C0034804,
umls-concept:C0087111,
umls-concept:C0330390,
umls-concept:C0521425,
umls-concept:C0549193,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2003941,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-1-28
|
|
pubmed:abstractText |
The majority of all breast cancers are hormone responsive, traditionally defined by the expression of oestrogen receptor (ER) alpha and/or progesterone receptors. In contrast to ERalpha, the clinical significance of the relatively recently identified ERbeta is still unclear. This study aimed to define the relationship between ERbeta and clinicopathological parameters in a mixed cohort of breast cancer and, furthermore, to investigate the impact of ERbeta expression on disease outcome.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1472-4146
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
61
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
197-203
|
|
pubmed:dateRevised |
2008-10-21
|
|
pubmed:meshHeading |
pubmed-meshheading:18223096-Adult,
pubmed-meshheading:18223096-Aged,
pubmed-meshheading:18223096-Aged, 80 and over,
pubmed-meshheading:18223096-Antineoplastic Agents, Hormonal,
pubmed-meshheading:18223096-Breast Neoplasms,
pubmed-meshheading:18223096-Estrogen Receptor alpha,
pubmed-meshheading:18223096-Estrogen Receptor beta,
pubmed-meshheading:18223096-Female,
pubmed-meshheading:18223096-Humans,
pubmed-meshheading:18223096-Lymphatic Metastasis,
pubmed-meshheading:18223096-Middle Aged,
pubmed-meshheading:18223096-Neoplasm Proteins,
pubmed-meshheading:18223096-Prognosis,
pubmed-meshheading:18223096-Survival Analysis,
pubmed-meshheading:18223096-Tissue Array Analysis,
pubmed-meshheading:18223096-Treatment Outcome,
pubmed-meshheading:18223096-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer.
|
|
pubmed:affiliation |
Division of Pathology, Department of Laboratory Medicine; Malmö University Hospital, Malmö, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
